Chorion and Amnion: Functions and Significance in Pregnancy

The chorion and amnion are two thin but vital membranes that surround and protect a developing fetus throughout pregnancy. Together they form the fetal membrane, a layered tissue that does far more than simply hold things in place. These membranes act as a physical barrier against infection, help regulate the volume and composition of amniotic fluid, produce hormones, and even express natural antimicrobial molecules. Understanding what they do, and what can go wrong with them, sheds light on everything from routine prenatal testing to premature birth and emerging therapies in regenerative medicine.

What the Chorion and Amnion Actually Are

The amnion is the inner membrane, the one closest to the fetus. It lines the amniotic cavity and is in direct contact with the amniotic fluid that cushions the baby. Despite being paper-thin, the amnion is responsible for most of the fetal membrane’s tensile strength, built from layers of collagen-rich connective tissue anchored to an epithelial layer by a basement membrane rich in Type IV collagen.¹ Between the amnion and the chorion lies a spongy extracellular matrix populated by various stromal cells, including mesenchymal cells, fibroblasts, and immune cells, all of which secrete the Type I and III collagens that give the membrane its structural backbone.

The chorion is the outer membrane. It sits between the amnion and the uterine wall, and its outermost layer consists of trophoblast cells that interface directly with maternal tissue. The chorion plays a particularly important role in immune tolerance, helping the mother’s immune system accept the genetically distinct fetus rather than rejecting it.¹ Early in development, the chorion and amnion arise from a single fold of tissue. In mice, researchers have shown that what was historically called the “posterior amniotic fold” actually gives rise to both membranes, prompting the suggested name “amniochorionic fold.”² In humans, the two membranes remain distinct layers but fuse together as pregnancy progresses, functioning as a unit by the second trimester.

How the Membranes Protect Against Infection

One of the most underappreciated jobs of the chorion and amnion is active antimicrobial defense. These membranes do not just sit passively between the fetus and the outside world. The chorion trophoblast layer and the amnion epithelium both produce natural antimicrobial peptides, including human beta-defensins (HBD1, HBD2, HBD3) and elafin. Research has localized these peptides to the trophoblast layers of both the placenta and the chorion, as well as to the amnion epithelium.³ When inflammatory signals appear, the membranes can ramp up production of these defensins. For example, beta-defensin 2 (BD2) expression in human amniotic epithelial cells increases in a dose- and time-dependent manner when exposed to bacterial components, and BD2 levels are higher in the amniotic membranes of women who deliver preterm with chorioamnionitis than in controls.⁴

This antimicrobial activity matters because the most common route of infection to the fetal membranes is ascending, meaning bacteria travel up from the vagina and cervix. The chorion trophoblast layer sits as the first line of defense against this upward migration, and the evidence suggests it functions as a key barrier to the progression of uterine infection.³

Amniotic Fluid Regulation and Hormone Production

The amniotic fluid that surrounds the fetus is not static. It cycles constantly, with large volumes moving in and out of the amniotic cavity every day. Near term, the fetus contributes roughly 500 to 700 milliliters daily through urine and swallows back about 200 to 450 milliliters, yet the net daily change in fluid volume is only about 5 to 10 milliliters in the third trimester.⁵ The total volume peaks at roughly 400 to 1,200 milliliters between 34 and 38 weeks, then declines by about 125 milliliters per week afterward.⁵

The fetal membranes help manage this balancing act. Researchers have identified water channel proteins called aquaporins (specifically AQP1) in the fetal membranes, which may help move water from the amniotic cavity across the placenta and into fetal circulation.⁶ Water also crosses the placenta through both direct pathways between cells and through cells themselves, and these aquaporin channels appear to facilitate that transfer.⁷

The membranes also have hormonal activity. The chorion is considerably more active than the amnion in producing progesterone, using substrates like pregnenolone and pregnenolone sulfate. The amnion, by contrast, produces relatively little progesterone.⁸ Progesterone is critical to maintaining pregnancy, and the chorion’s ability to produce it locally adds another layer of hormonal support beyond what the placenta provides.

Prenatal Diagnosis Through the Membranes

Both the chorion and the amniotic fluid have become essential tools for prenatal genetic testing. Chorionic villus sampling (CVS) involves taking a small biopsy of chorionic villi, the finger-like projections of the chorion that help form the placenta. CVS can be performed early, typically between 10 and 13 weeks of gestation, giving families genetic information in the first trimester.⁹ Amniocentesis, which samples amniotic fluid containing shed fetal cells, is typically performed later, at 15 to 21 weeks.⁹ A Cochrane systematic review notes that a major disadvantage of second-trimester amniocentesis is that results come later in pregnancy, which is why CVS was developed as an earlier alternative.¹⁰

The idea of using fetal membrane cells for diagnosis goes back to 1956, when researchers first isolated fetal trophoblast cells from amniotic fluid to identify fetal sex and genetic disorders. That invasive approach has been largely supplemented by techniques that isolate fetal cells from maternal blood, enabling screening for chromosomal conditions like Down syndrome and Edwards syndrome without entering the uterus at all.¹¹

Amniotic fluid also provides a window into fetal lung development. By counting lamellar bodies in the fluid, tiny packets of surfactant produced by fetal lungs, clinicians can predict whether a baby’s lungs are mature enough for life outside the womb. One study found that a lamellar body count above 51,000 per microliter predicted pulmonary maturity with 95% sensitivity and 96% specificity, helping guide decisions about timing delivery in high-risk pregnancies.¹²

When the Membranes Break Too Early

Premature rupture of membranes (PROM) and its preterm variant (PPROM, before 37 weeks) are among the most clinically significant complications involving the chorion and amnion. The membranes derive their strength from collagen in the extracellular matrix, and that collagen can be degraded by enzymes called matrix metalloproteinases (MMPs). A scoping review found that MMPs 2, 8, and 9 are the most studied in the context of PPROM, and that their activity can be triggered by inflammation.¹³ Earlier work showed that active forms of MMP2 and MMP9, freed from their natural inhibitors, are elevated in the amniotic fluid of women with PROM, and these enzymes can degrade the basement membranes of both the amnion and chorion.¹⁴

Environmental factors can worsen this vulnerability. Cigarette smoke exposure causes oxidative stress and programmed cell death in both amnion and chorion cells. In lab studies, fetal membranes exposed to cigarette smoke extract showed a dose-dependent decrease in the protective protein Bcl2 and increases in markers of apoptosis compared to unexposed tissue.¹⁵ Smoking also appears to lower levels of an enzyme (HPGD) involved in breaking down prostaglandins in the fetal membranes, which could alter the inflammatory environment and further weaken the tissue.¹⁶ These findings provide a biological explanation for the long-observed clinical link between smoking during pregnancy and higher rates of premature membrane rupture.

Membrane rupture at full term is an entirely different event. It is one of the only examples in normal human physiology where tissue failure is not a disease but a necessary step. The mechanisms that cause the membranes to give way during labor are still not fully understood, and researchers have noted that a complete picture requires understanding both the biological signals that weaken the tissue and the mechanical forces acting on it.

Chorioamnionitis and Infection of the Membranes

Chorioamnionitis, inflammation of the fetal membranes, is a significant cause of illness for both mothers and newborns. It most commonly develops when bacteria ascend from the lower genital tract into the uterine cavity, and the condition is closely associated with premature rupture of membranes.¹⁷ The infection is usually polymicrobial, with Ureaplasma urealyticum, Mycoplasma hominis, and certain anaerobic bacteria being the most frequently identified organisms.¹⁷

Once infectious organisms reach the chorioamnion, the body mounts an inflammatory response involving both maternal and fetal immune systems. This response involves a cascade of pro-inflammatory and inhibitory signaling molecules, which can lead to cervical ripening, further membrane injury, and either term or premature labor.¹⁸ In other words, the infection itself can trigger the very membrane weakening and labor that compounds the problem, creating a feedback loop that makes early detection and treatment crucial.

Amniotic Band Syndrome

A rarer but dramatic complication involves the amnion tearing during pregnancy. When the inner membrane ruptures prematurely while the chorion remains intact, shriveled strands of amnion can float in the fluid and become tangled around fetal limbs or other body parts. This is amniotic band syndrome, and the prevailing theory holds that it is caused by primary amnion rupture followed by entanglement of fetal parts by the resulting amniotic strands.¹⁹

In severe cases, these bands can constrict tightly enough to cause amputation of digits or limbs in utero. One reported case involved a woman with a septate uterus, where the reduced uterine space likely increased intrauterine pressure, promoting rupture of the amnion and allowing bands to encircle and amputate the fetus’s right upper extremity before birth.²⁰ Amniotic band syndrome can also occur as a rare complication after fetoscopic laser surgery for twin-twin transfusion syndrome, where the procedure can cause chorion-amnion membrane separation.²¹

Chorionicity in Twin Pregnancies

In twin pregnancies, whether twins share a chorion turns out to be one of the most important clinical distinctions. Monochorionic twins (sharing one chorion) face a substantially different risk profile than dichorionic twins (each with their own). Monochorionic-diamniotic twins, who share a chorion but have separate amnions, require close monitoring for conditions like twin-twin transfusion syndrome, unequal placental sharing, and twin anemia-polycythemia sequence.²²

The stakes are real. A large study found that women with monochorionic-diamniotic twins were about 2.2 times more likely to experience stillbirth than women with dichorionic twins. And when one twin died in utero, the co-twin died in utero or within seven days of life in roughly 43% of monochorionic cases, compared to under 3% of dichorionic cases.²³ This dramatic difference exists because monochorionic twins share placental blood vessel connections. When one twin is compromised, blood can shift suddenly through these shared vessels, endangering the surviving twin. Dichorionic twins, each with their own chorion and separate placental circulation, are largely protected from this cascade.

The Membranes After Delivery

The fetal membranes are discarded as medical waste after virtually every delivery, yet they have become valuable materials in regenerative medicine. Amniotic membrane has been used clinically for roughly a century, initially as a skin substitute and now across multiple surgical fields.²⁴ In ophthalmology, amniotic membrane transplantation has become a well-established treatment. The membrane can serve as a basement membrane substitute or a temporary biological bandage on the eye surface, and it has anti-inflammatory and anti-scarring properties along with growth factors that promote healing. It is used for conditions including chemical burns, persistent corneal defects, and diseases that cause conjunctival scarring.²⁵ Interest has also grown in applying amniotic and amnion-chorion membranes in oral surgery and general wound healing.²⁶

Amniotic fluid itself contains stem cells that have attracted considerable research attention. Certain cells isolated from amniotic fluid can differentiate into cell types representing all three embryonic germ layers without forming tumors, a combination of versatility and safety that makes them appealing candidates for regenerative therapies.²⁷ These cells have shown the ability to engraft in injured organs and modulate immune and repair responses, suggesting potential applications in treating degenerative and inflammatory diseases.²⁷ Researchers have proposed that amniotic fluid stem cells could eventually serve as a cellular resource for tissue engineering, drug screening, disease modeling, and cell replacement therapies.²⁸ Much of this work remains preclinical, but it represents a shift in how we think about fetal membranes: not just pregnancy tissue to be disposed of, but a source of biological material with therapeutic value.

An Evolutionary Innovation

The fetal membranes are not unique to humans, or even to mammals. The amnion, chorion, allantois, and yolk sac together form what biologists call the cleidoic egg, the self-contained egg that allowed vertebrates to reproduce on land without needing to return to water. Every reptile, bird, and mammal is an amniote, meaning its embryos develop within these membranes. In egg-laying species, the chorioallantoic membrane (a fusion of the chorion and allantois) serves as the main gas-exchange surface, functioning like a primitive lung pressed against the inside of the eggshell. In various live-bearing species across squamate reptiles, marsupials, and placental mammals, these same membranes were co-opted over evolutionary time to form increasingly complex placentas.²⁹ Highly complex placentas evolved independently multiple times across these groups, which makes the human placenta less a one-off invention and more a convergent solution to the same problem: keeping an embryo alive, nourished, and protected inside its parent.

1
PubMed Central. Fetal membrane at the feto-maternal interface: An underappreciated and understudied intrauterine tissue
2
PubMed Central. Amnion formation in the mouse embryo: the single amniochorionic fold model
3
PubMed. Expression of natural antimicrobials by human placenta and fetal membranes
4
PubMed Central. The Role of Beta-Defensin 2 in Preventing Preterm Birth with Chorioamnionitis: Insights into Inflammatory Responses and Epithelial Barrier Protection
5
Global Library of Women’s Medicine. Amniotic Fluid: Physiology and Assessment
6
PubMed. Expression and localization of aquaporin 1 and 3 in human fetal membranes
7
PubMed Central. Maternal-fetal fluid balance and aquaporins: from molecule to physiology
8
PubMed. Progesterone synthesis by human amnion, chorion, and decidua at term
9
PubMed Central. Comparative analysis of obstetric, perinatal, and neurodevelopmental outcomes following chorionic villus sampling and amniocentesis
10
PubMed Central. Amniocentesis and chorionic villus sampling for prenatal diagnosis
11
Placenta and Reproductive Medicine. The role of fetal membranes during gestation, at term, and preterm labor
12
Hellenic Journal of Obstetrics and Gynecology. Lamellar Body Count (LBC) in amniotic fluid for prediction of fetal lung maturity
13
PubMed Central. Matrix metalloproteinases in preterm prelabor rupture of membranes in the setting of chorioamnionitis: A scoping review
14
PubMed. MMP/TIMP imbalance in amniotic fluid during PROM: an indirect support for endogenous pathway to membrane rupture
15
PubMed. Cigarette smoke induces oxidative stress and apoptosis in normal term fetal membranes
16
PubMed. Smoking alters hydroxyprostaglandin dehydrogenase expression in fetal membranes
17
PubMed. Chorioamnionitis: from pathogenesis to treatment
18
PubMed Central. Diagnosis and Management of Clinical Chorioamnionitis
19
PubMed. Constrictive amniotic bands, amniotic adhesions, and limb-body wall complex: discrete disruption sequences with pathogenetic overlap
20
PubMed Central. Amniotic constriction band syndrome resulting in amputation caused by septate uterus: a case report
21
Case Reports in Women’s Health. Twin-twin transfusion syndrome in a dichorionic-diamniotic gestation with post-laser amniotic band sequence: A case report
22
PubMed. Ultrasound in twins: dichorionic and monochorionic
23
PubMed. Prospective risk of stillbirth: monochorionic diamniotic twins vs. dichorionic twins
24
Woodhead Publishing. Amniotic membrane in clinical medicine: History, current status, and future use
25
PubMed Central. Amniotic Membrane Transplantation in the Human Eye
26
PubMed Central. Surgical Application of Human Amniotic Membrane and Amnion-Chorion Membrane in the Oral Cavity and Efficacy Evaluation: Corollary With Ophthalmological and Wound Healing Experiences
27
PubMed. Concise Review: Amniotic Fluid Stem Cells: The Known, the Unknown, and Potential Regenerative Medicine Applications
28
PubMed. Stem Cells Derived from Amniotic Fluid: A Potential Pluripotent-Like Cell Source for Cellular Therapy?
29
PubMed. Evolution and development of fetal membranes and placentation in amniote vertebrates